Home > products > custom-nanocomposites
> lipid-nanoparticle-composite-materials
> liposomal-nanoparticles-encapsulating-apg-115-and-lenvatinib-100nm
Liposomal nanoparticles encapsulating APG-115 and Lenvatinib,100nm
Liposome nanoparticles encapsulated APG-115(Alrizomadlin) and Lenvatinib, 100nm
| Catalog # | Pkg Size | Price(USD) | Quantity | Buy this product |
|---|---|---|---|---|
| R-Mcs-539 | 100mg | 2509.00 | + Add to cart |
|
| R-Mcs-539 | 250mg | 5809.00 | + Add to cart |
|
|
|
||||
Product description
Liposomal nanoparticles encapsulating APG-115 and Lenvatinib (liposome nanoparticles loaded with APG-115 and lenvatinib) are a dual drug co loaded targeted nanoformulation with a particle size controlled at approximately 100 nm, aimed at synergistically enhancing anti-tumor efficacy, particularly suitable for combination therapy of solid tumors such as liver cancer and thyroid adenocarcinoma.
This product is only for scientific research and cannot be used on the human body.
| Appearance | Freeze-dried powder |
|---|---|
| Size | 100nm |
| Solubility | N/A |
| Drug loading | 4%(Lenvatinib); 4.5%(Alrizomadlin) |
| Encapsulation efficiency | 92%(Lenvatinib); 96%(Alrizomadlin) |
| Storage | -20℃, protected from light and moisture |
| Transportation | 4-25℃ temperature for up to 2 weeks |
| Stability | 6 months |
Document
Related Product

Items-$0.00

Email:
Tel.:
msds of Liposomal nanoparticles encapsulating APG-115 and Lenvatinib,100nm
RuixiBiotechCo.Ltd /KamulinBiotechco.ltd
Add: Room 20F 2002, Meiyuan Building, Yanta District, Xi’ an City, Shaanxi Province 710061 China
Tel: 02988811435
Fax: (86-29)8881-1435
Email: sales@ruixibiotech.com
Web: http://www.ruixibiotech.com


